U.S. Sunscreen Group Suggests User Fees To Expedite Ingredient Reviews

The Public Access to SunScreens Coalition will recommend a user-fee program to improve FDA’s work on TEAs for OTC ingredients. “Despite a number of OTC applications waiting for approval for several years, FDA has not completed the review of applications for any new sunscreen components,” PASS says.

More from Archive

More from HBW Insight